CRISPR_cas9_screens_cancer_genes-sc-4919
CRISPR_cas9_screens_cancer_genes
In this study, we employe CRISPR/cas9 genome-wide screen to identify genes that could be involved in CD8 mediated the immune killing. A couple of cancer cell lines will be used. The both in vitro and in vivo tumour models will be used. PCR gRNA amplicons will be used for illumina sequencing. 1) This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute please see http://www.sanger.ac.uk/datasharing/
We employed CRISPR/cas9 genome-wide screen to identify genes that could be involved in immune cell mediated the cancer cell killing. A couple of cancer cell lines will be used. PCR gRNA amplicons will be used for illumina sequencing.